1 |
CD4-induced
(65 times)
|
Virology (34 times)
|
Env (27 times) CD4bs (17 times) ADCC (14 times)
|
1999 Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
|
2 |
CD4-inducible
(8 times)
|
Virology (3 times)
|
ADCC (6 times) Env (4 times) Abs (2 times)
|
2011 An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.
|
3 |
CD4 binding
(2 times)
|
Acquired Immunodeficiency Syndrome (1 time)
|
hMAb (1 time) S-layer (1 time)
|
2002 Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions.
|
4 |
CD4-induced site
(2 times)
|
Zoology (1 time)
|
CD4bs (1 time) CoR (1 time) Env (1 time)
|
2003 Antigenic variations in the CD4 induced sites of the CCR5-tropic, pathogenic SHIVsf162p3 gp120 variants.
|
5 |
anti-CD4 induced
(1 time)
|
Biochemistry (1 time)
|
bNAbs (1 time) CD4bs (1 time)
|
2018 The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses.
|
6 |
anti-CD4-induced epitope
(1 time)
|
Virology (1 time)
|
Env (1 time) HIV-1 (1 time) mAbs (1 time)
|
2010 Enhanced exposure of human immunodeficiency virus type 1 primary isolate neutralization epitopes through binding of CD4 mimetic compounds.
|
7 |
CD4 binding-induced
(1 time)
|
Virology (1 time)
|
eAd (1 time) Env (1 time)
|
2010 Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates.
|